1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (650) 723-7448
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Therapeutic role of lymph node resection in endometrioid corpus cancer
A study of 12,333 patients
Article first published online: 14 SEP 2006
DOI: 10.1002/cncr.22185
Copyright © 2006 American Cancer Society
Additional Information
How to Cite
Chan, J. K., Cheung, M. K., Huh, W. K., Osann, K., Husain, A., Teng, N. N. and Kapp, D. S. (2006), Therapeutic role of lymph node resection in endometrioid corpus cancer. Cancer, 107: 1823–1830. doi: 10.1002/cncr.22185
Publication History
- Issue published online: 3 OCT 2006
- Article first published online: 14 SEP 2006
- Manuscript Accepted: 20 JUN 2006
- Manuscript Revised: 7 JUN 2006
- Manuscript Received: 13 APR 2006
REFERENCES
- 1, , , et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55: 10–30.Direct Link:
- 2, , . Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol. 1998; 70: 163–164.
- 3, , , et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004; 92: 744–751.
- 4NCCN. NCCN practice guidelines in oncology, v. 1.2005, uterine cancers. Available at http://www.nccn.org/professionals/physician_gls/PDF/uterine.pdf Accessed on July 28.
- 5, , , et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995; 56: 29–33.
- 6, , , et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23: 3668–3675.
- 7, , , et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol. 1998; 70: 165–171.
- 8, , . Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node-positive tumors. Obstet Gynecol. 1996; 87: 1041–1044.
- 9, , . Lymph node sampling and survival in endometrial cancer. Gynecol Oncol. 1998; 71: 340–343.
- 10Surveillance, Epidemiology, and End Results Program, SEER*Stat Database: Incidence — SEER 12 Regs Public-Use, Nov 2004 Sub (1988–2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Available at http://seer.cancer.gov/Released April 2005.
- 11, , , . Judging the therapeutic value of lymph node dissections for melanoma. J Am Coll Surg. 2000; 191: 16–22; discussion 22–23.
- 12, . Breast cancer survival according to number of nodes removed. Ann Surg Oncol. 2003; 10: 1152–1159.
- 13, , , . Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol. 2002; 20: 1793–1799.
- 14, , , et al. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol. 1998; 5: 140–149.
- 15, , , et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001; 19: 157–163.
- 16, , . Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol. 1997; 176: 777–788.
- 17. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol. 2001; 82: 371–374.
- 18, , , et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol. 2005; 105: 487–493.
- 19, , , et al. Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma. Gynecol Oncol. 1994; 54: 292–297.
- 20, , , et al. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol. 2002; 86: 28–33.
- 21. Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol. 2000; 182: 1328–1334.
- 22, , , , . Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy. Anticancer Res. 1998; 18: 1897–1902.
- 23, , , , . Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol. 1993; 49: 177–180.
- 24, , , et al. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol. 2001; 82: 375–379.